Travere Therapeutics, Inc. (TVTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$27.21
Day's range
$29.31

Travere Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JANUS HENDERSON GROUP PLC 05/18/2026 11.42 M $339.25 M   8.64% 12.80%
FMR LLC 05/15/2026 10.97 M $325.86 M   14.04% 12.29%
BLACKROCK, INC. 05/13/2026 7.79 M $231.50 M   -0.98% 8.73%
STATE STREET CORP 05/15/2026 4.96 M $147.36 M   4.27% 5.56%
ARMISTICE CAPITAL, LLC 05/15/2026 4.90 M $145.50 M   30.12% 5.49%
PERCEPTIVE ADVISORS LLC 05/29/2026 4.14 M $123.08 M   -3.17% 4.64%
05/15/2026 4.05 M $120.20 M   100.00% 4.54%
MACQUARIE MANAGEMENT HOLDINGS, INC. 05/15/2026 3.27 M $97.17 M   -13.33% 3.67%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 2.37 M $70.41 M   10.55% 2.66%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 1.97 M $58.43 M   -12.46% 2.20%
STEPHENS INVESTMENT MANAGEMENT GROUP LLC 04/28/2026 1.80 M $53.43 M   4.46% 2.02%
GOLDMAN SACHS GROUP INC 05/15/2026 1.72 M $51.09 M   -7.95% 1.93%
05/08/2026 1.71 M $50.78 M   100.00% 1.92%
KYNAM CAPITAL MANAGEMENT, LP 05/15/2026 1.57 M $46.62 M   202.97% 1.76%
EMERALD ADVISERS, LLC 05/04/2026 1.56 M $46.26 M   -2.32% 1.75%
TWO SIGMA INVESTMENTS, LP 05/15/2026 1.51 M $44.81 M   30.38% 1.69%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2026 1.48 M $43.91 M   -33.13% 1.66%
BANK OF AMERICA CORP /DE/ 05/18/2026 1.35 M $39.96 M   -27.31% 1.51%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 1.28 M $38.10 M   42.28% 1.44%
BIOIMPACT CAPITAL LLC 05/15/2026 1.13 M $33.67 M   100.00% 1.27%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 1.02 M $30.37 M   27.95% 1.15%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 977.00 K $29.03 M   -66.62% 1.10%
EMERALD MUTUAL FUND ADVISERS TRUST 05/04/2026 945.03 K $28.08 M   -0.36% 1.06%
NUVEEN, LLC 04/30/2026 938.57 K $27.88 M   -5.54% 1.05%
DEUTSCHE BANK AG\ 05/06/2026 925.92 K $27.51 M   5.02% 1.04%
FIERA CAPITAL CORP 05/12/2026 900.87 K $26.76 M   3.07% 1.01%
UBS GROUP AG 05/05/2026 856.76 K $25.45 M   102.73% 0.96%
D. E. SHAW & CO., INC. 05/15/2026 836.54 K $24.85 M   -23.57% 0.94%
KYNAM CAPITAL MANAGEMENT, LP 05/15/2026 800.00 K $23.77 M   100.00% 0.90%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 790.81 K $23.50 M   -2.15% 0.89%
NORTHERN TRUST CORP 05/14/2026 781.42 K $23.22 M   2.62% 0.88%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 746.84 K $22.19 M   100.00% 0.84%
ENSIGN PEAK ADVISORS, INC 05/13/2026 715.71 K $21.26 M   -11.12% 0.80%
CAPTION MANAGEMENT, LLC 05/15/2026 681.00 K $20.23 M   2.19% 0.76%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 677.10 K $20.12 M   -5.75% 0.76%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 669.16 K $19.88 M   64.73% 0.75%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 612.62 K $18.20 M   100.00% 0.69%
BARCLAYS PLC 05/15/2026 610.60 K $18.14 M   188.02% 0.68%
PANAGORA ASSET MANAGEMENT INC 05/14/2026 592.91 K $17.62 M   0.95% 0.66%
ABRDN PLC 04/29/2026 557.15 K $16.55 M   7.48% 0.62%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/14/2026 546.00 K $16.22 M   100.00% 0.61%
EVERSEPT PARTNERS, LP 05/15/2026 542.61 K $16.12 M   -53.82% 0.61%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 529.76 K $14.68 M   -0.91% 0.59%
INVESCO LTD. 05/12/2026 523.71 K $15.56 M   10.47% 0.59%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/15/2026 520.60 K $15.47 M   100.00% 0.58%
LEGAL & GENERAL GROUP PLC 05/08/2026 451.06 K $13.40 M   -15.99% 0.51%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 404.81 K $12.03 M   2.52% 0.45%
HSBC HOLDINGS PLC 04/30/2026 396.85 K $11.79 M   100.00% 0.44%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 376.70 K $11.19 M   234.84% 0.42%
CANDRIAM S.C.A. 04/30/2026 370.00 K $10.99 M   -21.04% 0.41%

Travere Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 344 institutional investors and hedge funds held shares of Travere Therapeutics Inc. The most heavily invested institutionals were:

JANUS HENDERSON GROUP PLC: 11.42 M

FMR LLC: 10.97 M

BlackRock, Inc.: 7.79 M

STATE STREET CORP: 4.96 M

ARMISTICE CAPITAL, LLC: 4.9 M

PERCEPTIVE ADVISORS LLC: 4.14 M

113.61% of Travere Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 114.47 M shares in the last 24 months. This purchase volume represents approximately $3.32 B in transactions.